The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
National predictors and trends for androgen deprivation therapy use in low-risk prostate cancer.
 
David Yang
No Relationships to Disclose
 
Vinayak Muralidhar
No Relationships to Disclose
 
Brandon Arvin Virgil Mahal
No Relationships to Disclose
 
Michelle Daniel Nezolosky
No Relationships to Disclose
 
Marie Vastola
No Relationships to Disclose
 
Shelby Labe
No Relationships to Disclose
 
Peter F. Orio
Consulting or Advisory Role - Augmenix; Bard Medical
 
Neil E. Martin
Consulting or Advisory Role - Via Oncology
 
Martin T. King
No Relationships to Disclose
 
Quoc-Dien Trinh
No Relationships to Disclose
 
Christopher Sweeney
Stock and Other Ownership Interests - Leuchemix
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Genentech/Roche; Janssen Biotech; Pfizer; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Exelixis (Inst); Janssen Biotech (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Leuchemix, Parthenolide, Dimethylaminoparthenolide. Exelixis: Abiraterone plus cabozantinib combination
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Foundation Medicine; GlaxoSmithKline; Merck; Novartis; Pfizer; Prometheus; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)
 
Paul L. Nguyen
Consulting or Advisory Role - Ferring; GenomeDx; Medivation
Research Funding - Astellas Pharma
Patents, Royalties, Other Intellectual Property - Wife has a patent on volatile diagnostics of infections (I)